These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7633391)

  • 21. Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm.
    Li WP; Smith CJ; Cutler CS; Hoffman TJ; Ketring AR; Jurisson SS
    Nucl Med Biol; 2003 Apr; 30(3):241-51. PubMed ID: 12745015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis.
    Nilsson S; Wikström M; Ericsson A; Wikström G; Waldenström A; Oksendal A; Hemmingsson A
    Acta Radiol; 1995 Jul; 36(4):346-52. PubMed ID: 7619610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes.
    Duncan JR; Franano FN; Edwards WB; Welch MJ
    Invest Radiol; 1994 Jun; 29 Suppl 2():S58-61. PubMed ID: 7928272
    [No Abstract]   [Full Text] [Related]  

  • 24. A molecular CT blood pool contrast agent.
    Vera DR; Mattrey RF
    Acad Radiol; 2002 Jul; 9(7):784-92. PubMed ID: 12139092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry.
    Bulte JW; Wu C; Brechbiel MW; Brooks RA; Vymazal J; Holla M; Frank JA
    Invest Radiol; 1998 Nov; 33(11):841-5. PubMed ID: 9818319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dy-EOB-DTPA: tolerance and pharmacokinetics in healthy volunteers and preliminary liver imaging in patients.
    Krause W; Mahler M; Hanke B; Milius W; Kaufmann J; Rogalla P; Hamm B
    Invest Radiol; 2001 Aug; 36(8):431-44. PubMed ID: 11500593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 166Ho-labeled hydroxyapatite particles: a possible agent for liver cancer therapy.
    Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
    Cancer Biother Radiopharm; 2009 Feb; 24(1):7-14. PubMed ID: 19216630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
    Breeman WA; van der Wansem K; Bernard BF; van Gameren A; Erion JL; Visser TJ; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):312-5. PubMed ID: 12552352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical and biological evaluation of 153Sm and 166Ho complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylphosphonic acid monoethylester) (H4 dotp OEt).
    Försterová M; Jandurová Z; Marques F; Gano L; Lubal P; Vanek J; Hermann P; Santos I
    J Inorg Biochem; 2008 Jul; 102(7):1531-40. PubMed ID: 18374985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
    Ericsson A; Bach-Gansmo T; Niklasson F; Hemmingsson A
    Acta Radiol; 1995 Jan; 36(1):41-6. PubMed ID: 7833167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.
    Rajendran JG; Eary JF; Bensinger W; Durack LD; Vernon C; Fritzberg A
    J Nucl Med; 2002 Oct; 43(10):1383-90. PubMed ID: 12368378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of dechelation of gadopentetate dimeglumine in rats.
    Kasokat T; Urich K
    Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
    Lewis MR; Zhang J; Jia F; Owen NK; Cutler CS; Embree MF; Schultz J; Theodore LJ; Ketring AR; Jurisson SS; Axworthy DB
    Nucl Med Biol; 2004 Feb; 31(2):213-23. PubMed ID: 15013487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial cell death in reperfused and nonreperfused myocardial infarctions. MR imaging with dysprosioum-DTPA-BMA in the pig.
    Nilsson S; Wikström G; Ericsson A; Wikström M; Oksendal A; Waldenström A; Hemmingsson A
    Acta Radiol; 1996 Jan; 37(1):18-26. PubMed ID: 8611317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
    Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core-shell structured gold nanoparticles as carrier for
    Wang R; Ponsard B; Wolterbeek H; Denkova A
    EJNMMI Radiopharm Chem; 2022 Jul; 7(1):16. PubMed ID: 35852733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary dosimetric evaluation of (166)Ho-TTHMP for human based on biodistribution data in rats.
    Yousefnia H; Zolghadri S; Jalilian AR; Tajik M; Ghannadi-Maragheh M
    Appl Radiat Isot; 2014 Dec; 94():260-265. PubMed ID: 25255303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of dysprosium in monkey serum by inductively-coupled plasma atomic emission spectrometry (ICP-AES) after the administration of Sprodiamide Injection, a new contrast medium for magnetic resonance imaging.
    Lai JJ; Jamieson GC
    J Pharm Biomed Anal; 1993; 11(11-12):1129-34. PubMed ID: 8123724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.